ImmunoACT
Cell & Gene Therapy development
- B2B
- B2C
About ImmunoACT
A pioneer in India's Cell & Gene Therapy development, focusing on affordable CAR-T cell therapies for blood cancers Founded in 2018
Key facts
- Industry
- Biotechnology Research
- Company size
- 51–250 employees
- Headquarters
- navi mumbai, maharashtra, India
- Founded
- 2018
- Revenue
- $2.6M – $20.8MTamtam estimate
- Website
- immunoact.com
- linkedin.com/company/immunoact
ImmunoACT at a glance
ImmunoACT is a B2B/B2C company in the Biotechnology Research industry, headquartered in navi mumbai, maharashtra, India.
ImmunoACT was founded in 2018.
ImmunoACT has 51–250 employees.
ImmunoACT's revenue is $2.6M – $20.8M (Tamtam estimate).
Selling to companies like ImmunoACT?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies